Taiwan FDA registration b812709f275b793e0fbd56f90fdfc97c
"DXN" alkaline phosphatase test reagent
TW: “德信”鹼性磷酸酶檢驗試劑
Taiwan·Risk Class 2·DIASYS DIAGNOSTIC SYSTEMS GMBH·Registered Apr 08, 2020 – Apr 08, 2030ActiveRegistration details
- Analysis ID
- b812709f275b793e0fbd56f90fdfc97c
- Customs Code
- DHA05603346606
Company information
- Manufacturer
- DIASYS DIAGNOSTIC SYSTEMS GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- TUNYEN ENTERPRISE CORPORATION
Product details
- Intended Use
- A diagnostic reagent used in optical colorimetric analysis instruments to quantify alkaline phosphatase (AP) in serum or plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1050 Alkaline phosphatase or isoenzyme testing system
- Import Information
- import
Dates and status
- Registration Date
- Apr 08, 2020
- Expiry Date
- Apr 08, 2030
About this record
Access comprehensive regulatory information for "DXN" alkaline phosphatase test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b812709f275b793e0fbd56f90fdfc97c and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The authorized representative in Taiwan is TUNYEN ENTERPRISE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices